The device is designed for the removal of carbon dioxide in the anesthesia circuit, which could make anesthesia safer and prevent patient memory loss and other forms of cognitive dysfunction, according to the report. Dr. Schmidt hopes to bring the device from “bench to bedside” by 2014, pending clinical trials and a regulatory process.
Read the Newswise report on Dr. Schmidt’s device.
Read more on anesthesia:
–Oklahoma Anesthesiologist Fined on Probation for Self-Injecting Demerol at Work
–5 Ways Anesthesia Providers Can Improve Patient Safety
–Surgeon and Anesthesiologist Perception of Turnover Times May Be Flawed
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.